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Abstract 
A model system for membrane fusion, inspired by SNARE proteins and based on two complementary lipopeptides 
CPnE4 and CPnK4, has been recently developed. It consists of cholesterol (C), a poly(ethylene glycol) linker (Pn) and 
either a cationic peptide K4 (KIAALKE)4 or an anionic peptide E4 (EIAALEK)4. In this paper, fluorescence spectroscopy 
is used to decipher distinct but complementary roles of these lipopeptides during early stages of membrane fusion. 
Molecular evidence is provided that different distances of E4 in CPnE4 and K4 in CPnK4 from the bilayer represent an 
important mechanism, which enables fusion. Whereas E4 is exposed to the bulk and solely promotes membrane 
binding of CPnK4, K4 loops back to the lipid-water interface where it fulfills two distinct roles: it initiates bilayer contact 
by binding to CPnE4 containing bilayers; and it initiates fusion by modulating the bilayer properties. The interaction 
between CPnE4 and CPnK4 is severely down-regulated by binding of K4 to the bilayer and possible only if the 
lipopeptides approach each other as constituents of different bilayers. When the complementary lipopeptides are 
localized in the same bilayer, hetero-coiling is disabled. These data provide crucial insights as to how fusion is 
initiated and highlight the importance of both peptides in this process.     
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Introduction 
Fusion of cellular membranes has recently attracted considerable scientific attention, not only for being ubiquitous 
and vital in living organisms, but also for its potential to be used for in vivo applications. Fusion of membranes in 
living cells is crucial for a number of cellular functions, e.g. the controlled release of neurotransmitters, fertilization,  
communication, and material exchange in eukaryotic cells.1,2 In eukaryotic cells, this process is mediated by so-called 
SNARE proteins (soluble N-ethyl-maleimide-sensitive factor attachment protein receptor), which have been 
proposed to be involved in all intracellular events of membrane fusion.3 The fusing membranes are brought into 
contact by the formation of a tetrameric coiled-coil between three different membrane-tethered SNARE proteins. 
This so-called coiled-coil interaction is established by α-helical portions of the proteins interacting with each other 
in a specific manner resulting in the formation of a stable complex.4,5 
Despite the huge diversity of systems where fusion can occur, the fusion cascade shares a few common features: 
first, contact between two membranes is developed and accompanied by disruption of the contact site. This is 
followed by fusion of the proximal leaflets and lipid mixing, which culminates in opening of a fusion pore and content 
mixing.1,6,7 Attempts to mimic and understand the mechanism of membrane fusion has led to the development of 
several artificial model systems using various strategies, e.g. double stranded DNAs, covalent or hydrogen-bonding 
motifs and coiled-coil interactions between two complementary α-helices.8–11 Recently, a model system inspired by 
the molecular recognition of native SNARE proteins has been developed.12 The fusogens consist of a set of two 
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complementary lipopeptide molecules (Figure 1). Each of these lipopeptides contains a recognition domain 
comprising one of the complementary coiled-coil-forming peptides E or K, cholesterol which serves as a membrane 
anchor and a poly(ethylene glycol) (P) of variable length. The latter molecule serves as a linker between the 
cholesterol anchor and the peptide. If the cationic peptide K4 (KIAALKE)4 is employed, the construct is known as 
CPnK4, where n denotes the number of ethylene glycol units, and CPnE4 represents the construct containing the 
anionic peptide E4 (EIAALEK)4. The lipopeptides CPnK4 and CPnE4 interact with each other by the formation of a coiled-
coil motif resulting from the interaction of peptide E4 and K4. This coiled-coil is strong enough to bring the two 
opposing membranes into close contact and induce effective and leakage-free fusion in vitro and in vivo.12,13 Both 
lipopeptides can be incorporated in artificial as well as plasma membranes of living cells in a facile manner by adding 
the lipopeptides directly to either liposomes or cells. This strategy opens up new possibilities for in vivo 
applications.13,14,15 However, the exact mechanism of lipopeptide-mediated membrane fusion still remains 
unknown. In this paper, we employ FCS (fluorescence correlation spectroscopy) and FCCS (fluorescence cross-
correlation spectroscopy) techniques and FRET (Förster resonance energy transfer) to uncover distinct but 
complementary roles of CPnE4 and CPnK4 lipopeptides during the initial steps of membrane fusion. We show for the 
first time that the interaction between the complementary lipopeptides, which is a pre-requisite for establishing a 
membrane contact between two approaching bilayers, is strongly down-regulated by the looping-back of K4 to the 
lipid bilayer. The majority of CPnK4 is in fact needed to poise the bilayer for undergoing fusion whereas only a minor 
fraction of CPnK4 is then used to bind CPnE4 on an approaching bilayer. Conversely, E4 in CPnE4 is largely exposed to 
the bulk and works solely as a handle for CPnK4. This paper provides molecular evidence that different distances, 
facilitated by different PEG-spacer lengths, of E4 in CPnE4 and K4 in CPnK4 from the lipid-water interface represent an 
important mechanism which enables efficient fusion. 
 
Figure 1.  Chemical structures of CPnE4 and CPnK4 lipopeptides. A lipopeptide consists of a cholesterol moiety (C), a 
flexible poly(ethylene glycol) (PEG) linker of either 4 or 12 PEG units (P4 or P12) and one of the complementary 
peptides E or K. The lipopeptides were fluorescently labelled with either Atto-488 or Atto-655 at the C terminus of 
the peptide by a thiol-maleimide coupling. 
Results and Discussion 
 
Strong binding of K4 to the bilayer hampers a direct interaction of E4 with K4 
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In alignment with previous studies, we used 1,2-dioleoyl-sn-glycero-3-phosphocholine/1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine/Cholesterol    (DOPC/DOPE/Chol) (50/25/25 mol%) lipid mixtures as fusion 
of such DOPE rich membranes was found to be highly efficient due to induction of negative curvature by 
the DOPE lipids.16–19 The extent of membrane binding was determined by measuring the fluorescence 
intensity of the peptides bound to the bilayer of giant unilamellar vesicles (GUVs) and confirmed by z-scan 
FCS diffusion measurements (see Supporting Information). The GUVs incubated solely with a fluorescent 
peptide K4-Atto-655 exhibited approximately 6.5 times higher intensity than those incubated with the same 
concentration of E4-Atto-655, showing a higher affinity of K4 to the lipid bilayer (Figure 2). The situation 
changed drastically when the vesicles were decorated with one of the complementary lipopeptides prior to 
addition of either E4-Atto-655 or K4-Atto-655 (Figure 2). Binding of both E4-Atto-655 and K4-Atto-655 
significantly improved, which demonstrates the mutual affinity of the complementary peptides. 
 
Figure 2. Fluorescence intensities (averaged number of photons per area) of fluorescently labelled peptides 
K4-Atto-655 (olive) and E4-Atto-655 (black) adsorbed on the surface of DOPC/DOPE/Chol (50/25/25 mol%) 
GUVs give information about the surface concentration of the peptides at the lipid bilayer. The GUVs were 
prepared either with or without 1 mol% of one of the complementary lipopeptides (LPs) (type of the 
lipopeptide is further specified below the x axis). GUVs were scanned 30 minutes after the addition of the 
peptide (0.4 mol%). 
 
To understand how binding of the peptides to the complementary lipopeptides progresses at the molecular 
level, fluorescence correlation spectroscopy (FCS) experiments were conducted. An output of an FCS 
measurement is an autocorrelation function (Gauto), which contains information about diffusion of 
fluorescently labelled molecules (Figure 3A). The diffusion coefficient D of K4-Atto-655 in bilayers with and 
without 1 mol% of CP4E4  remained almost the same and was similar to the diffusion coefficient of 
fluorescently labelled DOPE-Atto-655 lipids in the presence of 1 mol% of K4 (Table 1).  Moreover, the 
diffusion of K4-Atto-655 in the presence of 1 mol% of CP4E4 was slightly higher than the diffusion of CP4E4-
Atto-488 in the presence of 1 mol% of K4. The last two observations would indicate that a considerable 
fraction of K4-Atto-655 stays in the bilayer unbound to CP4E4-Atto-488. The amount of unbound K4-Atto-655 
was further quantified by fluorescence cross-correlation spectroscopy (FCCS) experiments between K4-Atto-
655 and CP4E4-Atto-488  (see SI for further details). In Figure 3B the measured cross-correlation amplitude 
𝐺𝐺cross(0) was normalized (yielding 𝐺𝐺crossnorm(0)) and plotted against the concentration of K4-Atto-655 in the 
bilayer (see SI for details). Then, 𝐺𝐺crossnorm(0) = 1 should be obtained if all K4-Atto-655 binds to CP4E4-Atto-488 
molecules. 𝐺𝐺crossnorm(0) in Figure 3B grows with increasing concentration of K4-Atto-655 until it reaches a 
maximum value of about 25 %. Thus, considerable fractions of K4-Atto-655 and CP4E4-Atto-488 do not bind 
to each other in the lipid bilayer.   
Similarly, diffusion of E4-Atto-655 in the presence of CP4K4-Atto-488 significantly differed from the diffusion 
of CP4K4-Atto-488 in in the presence of 1 mol% of E4 (Table 1). Moreover, the diffusion of E4-Atto-655 in 
pure DOPC/DOPE/Chol (50/25/25 mol%) bilayers was much faster than the previously reported diffusion of 
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K4-Atto-655. Both observations point to a weaker interaction of peptide E4 with the bilayer. Interestingly, it 
follows from the FCCS analysis of CP4K4-Atto-488 and E4-Atto-655 (Figure 3B) that only 35 % of the maximum 
value of 𝐺𝐺cross(0) were reached in this case. In summary, we show that membrane embedded CP4E4 and 
CP4K4 do form hetero-coils with the complementary K4 and E4, but the fraction of stable hetero-coils is low. 
It appears that the direct interaction of E4 with K4 is hampered by preferable interactions of K4 with the 
bilayer. In the case when K4 binds to CP4E4 containing vesicles, CP4E4 works only as a handle which brings K4 
close to the lipid bilayer where K4 prefers to interact with the bilayer rather than with CP4E4. In the other 
case when E4 is approaching CP4K4-containing vesicles E4 can bind only by means of CP4K4. This lipopeptide, 
however, is unable to bind E4 efficiently because of its high affinity to the bilayer. 
 
Figure 3. (Left): Representative auto-correlation functions Gauto for CP4E4-Atto-488 and K4-Atto-655 obtained 
from an FCS measurement and the corresponding cross-correlation function (Gcross) obtained from a parallel 
FCCS measurement. (Right): The normalized cross-correlation amplitude, which reports on the extent of 
interaction between one of the peptides and the complementary lipopeptide, as a function of the peptide 
to lipopeptide ratio on DOPC/DOPE/Chol (50/25/25 mol%) bilayers. The average value of 𝐺𝐺crossnorm was 
calculated based on measurements on at least 5 GUVs. 
 
Table 1. Diffusion coefficients (D) together with their standard deviations for K4-Atto-655 and E4-Atto-655 
peptides adsorbed on DOPE/DOPC/Chol (50/25/25 mol%) bilayers. The GUVs were pre-incubated with 1 
mol% of one of the (lipo)peptides specified in the first column. Furthermore, the table shows D for a DOPE-
Atto-488 reference probe.   
GUVs pre-incubated 
with 1 mol% of 
D (μm2/s) 
K4-Atto-655 E4-Atto-655 CP4K4-Atto-488 CP4E4-Atto-488 DOPE-Atto-488 
No LPs 9.13 ± 0.63 132 ± 13 - - 9.85 ± 0.36 
K4 - - - 7.9 ± 0.55 9.73 ± 0.54 
CP4E4 9.27 ± 0.32 - - - - 
E4 - - 5.67 ± 0.75 - 10.09 ± 0.58 
CP4K4 - 10.24 ± 0.95 - - - 
 
Different distances of the peptide segments E4 or K4 from the lipid water interface prevent lipopeptides 
from hetero-coiling 
Importantly, no detectable hetero-coiling occurs when both lipopeptides CPnE4 and CPnK4 are reconstituted 
in the same bilayer at roughly the same concentration. This is documented by the cross-correlation 
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amplitude for CP4E4-Atto-488 and CP4K4-Atto-655 equal to zero at low lipopeptide concentrations (<< 1 mol 
%, 𝐺𝐺cross(0) = 0, Figure 4A) but also by FRET at considerably higher lipopeptide concentrations (about 1 
mol %, Figure 4B), at which fusion normally progresses. The efficiency of FRET E depends on the average 
distance of the donors from the acceptors. For the case of homogeneously distributed donors and acceptors 
in a lipid bilayer, the dependence of E on the acceptor to lipid ratio can be obtained from a model derived 
by Baumann and Fayer (black line in Figure 4): it is steep at low acceptor to lipid ratios and flattens off 
typically at ratios exceeding 2 mol% of the acceptors.20 Clustering of the donors with the acceptors (i.e. 
hetero-coiling of CP4E4-Atto-488 with CP4K4-Atto-655) brings the donors effectively closer to the acceptors, 
enhancing the efficiency of FRET in comparison to the expected theoretical value for a given acceptor to 
lipid ratio. The hetero-coiling of lipopeptides should thus lead to a steeper dependence of E on the acceptor 
to lipid ratio than would correspond to a homogeneous distribution of the labelled lipopeptides. The 
experimental dependency shown in Figure 4B perfectly follows the theoretical one (to understand in more 
detail how the theoretical dependence is calculated see SI). This means that hetero-coils of the lipopeptides 
in the membrane are not formed at higher, and in terms of fusion more relevant, concentrations either (up 
to 1.2 mol%). Such behaviour might suggest the two following scenarios: 1) hetero-coiling of lipopeptides is 
outcompeted by the formation of homo-coils or 2) the peptide segments of the complementary 
lipopeptides cannot come close enough to each other to facilitate hetero-coiling. 
 
Figure 4. (A): Representative auto-correlation functions (Gauto) for CP4E4-Atto-488 and CP4K4-Atto-655 and 
the corresponding cross-correlation function (Gcross); (B): FRET efficiency E as a function of the acceptor to 
lipid ratio. The donor/acceptor pair consisted of CP4E4-Atto-488/CP4K4-Atto-655 fluorescently labelled 
lipopeptides. The experimental data are displayed as solid red points. A theoretical dependence is shown 
for reference (black line with empty black squares). It was assumed in this dependence that the donors were 
homogeneously distributed in two parallel planes (separated by the distance dl-l(CP4E4-Atto-488)  = d + 2dl-
m(CP4E4-Atto-488)) whereas acceptors were distributed in two other parallel planes (separated by the 
distance dl-l(CP4K4-Atto-655)  = d + 2dl-m(CP4K4-Atto-655)). See Figure S1 for further explanation. The donor 
to lipid ratio was 0.3 mol%.  
 
Scenario 1), i.e. homo-coiling of CPnE4 with CPnE4, or CPnK4 with CPnK4 has already been shown to impair 
membrane fusion.21 It has also been shown that aggregation of homo- and hetero-coils might enhance the 
efficiency of fusion or that it can induce membrane curvature and rupture, which might in turn mediate 
fusion.2,16,17,19,22–24 However, neither our FCCS or brightness experiments conducted at low lipopeptide 
concentrations, nor FRET experiments performed at higher lipopeptide concentrations pointed to the 
presence of CPnE4 or CPnK4 homo-coils (see SI for results). Despite an obvious absence of stable homo-coils 
in the DOPC/DOPE/Chol (50/25/25 mol%) bilayer, individual lipopeptide molecules interfere with each other 
when present at fusion-relevant concentrations. This follows from the observation that after addition of 1 
mol % of the lipopeptides to the bilayer, the diffusion of a lipopeptide labelled by Atto-488 is slowed down 
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more than the diffusion of a lipid-like reference probe DiD (1,1'-Dioctadecyl-3,3,3',3'-
Tetramethylindodicarbocyanine-5,5'-Disulfonic Acid, D(lipopeptide)/D(DiD) < 1, see the upper panel of 
Figure 5). It is likely that the relatively bulky headgroups of the lipopeptides consisting of a poly(ethylene 
glycol) chain and a peptide moiety E4 or K4 interfere with each other and cannot therefore move freely. 
According to Šachl et al., the diffusion under such conditions may still appear free although it is impeded, 
depending on the overall concentration of the obstacles.25 In other words, individual CP4K4 or CP12K4 
molecules can act as obstacles for each other at such elevated concentrations.  
 
Figure 5. The diffusion coefficients D of lipopeptides (LPs) CPnE4 or CPnK4 normalized by the diffusion 
coefficient of DiD (upper panel) and the diffusion coefficient of the membrane marker DiD (lower panel) 
shown for the lipopetide concentration of 1 mol% in DOPC/DOPE/Chol (50/25/25 mol%) GUVs. 
 
Scenario 2) could happen if the positions of the peptide segments of the lipopeptides differed so much that 
the peptides would not encounter each other. This hypothesis can be tested by FRET.26 By assuming that 
the donors (peptide segments of CPnE4-Atto-488/CPnK4-Atto-488) were found in one plane whereas the 
acceptors (DiD) were localized at the lipid-water interface in the plane parallel to the first one, the distance 
between these planes could be determined (Figure 6). As shown in panel A of Figure 6, the average time-
resolved fluorescence decays of CP12E4-Atto-488 and CP12K4-Atto-488 differ from each other significantly. 
Because the surface concentration of the acceptors was kept at a constant level the observed differences 
could have only been caused by different distances of the peptide segments from the interface. Fitting the 
decays with a model derived by Baumann and Fayer yielded quantitative information regarding the 
distances.20 The distance dCPK-m of Atto-488 attached to peptide K4 in CPnK4 was found, on average, 2.2 – 2.3 
nm from the acceptor plane (= the lipid-water interface). The estimated maximal theoretical distances of 
Atto-488 from this plane were calculated to be 6.5 nm for CP4K4 and 9.3 nm for CP12K4, respectively. 
Comparison of these values with the measured distance suggests ‘looping back’ of the peptide segments in 
CP4K4 and CP12K4 to the lipid-water interface. This finding is in line with previous findings, which reported 
the tendency of peptide K3 and the peptide segment CPnK3 to snorkel in the lipid bilayer.17,19 Conversely, the 
distance dCPE-m of Atto-488 attached to CPnE4 from the bilayer surface equalled on average (6.7 ± 0.6) nm for 
CP4E4 nm or (6.0 ± 0.5) nm for CP12E4, respectively (Figure 6D). This means that CPnE4 is in contrast to CPnK4 
largely exposed to the bulk. Furthermore, as indicated by different time-resolved fluorescence decays 
obtained from individual GUVs (Figure 6B and S5) the peptide segments of both lipopeptides are broadly 
distributed around the corresponding average distances from the lipid-water interface. In summary, E4 in 
CPnE4, which is found more apart from the bilayer, has practically no chance to interact with K4 in CPnK4, 
which is in contrast localized close to the lipid-water interface. Hetero-coils can apparently be formed only 





Figure 6. (A) Average normalized time-resolved fluorescence decays of CPnE4-Atto-488 and CPnK4-Atto-488 
donors in the presence of DiD acceptors. (B) An example of varying decays of CP4K4-Atto-488 in the presence 
of DiD obtained for a set of different GUVs. (C-D) Schematic pictures outlying the proposed orientations of 
CPnK4 (C) and CPnE4 (D) with respect to the lipid bilayer. The arrows point to the directions in which FRET 
can occur: within the same leaflet as well as across the lipid bilayer.    
 
Peptide K as an essential modulator of the lipid bilayer 
The different distances of the peptide segments of CPnE4 and CPnK4 from the membrane strongly suggest 
that K4 will influence the DOPC/DOPE/Chol (50/25/25 mol%) bilayer more than E4. Disruptive behaviour has 
already been reported for the lipopeptide CPnK3 and peptide K3, which are shorter peptides. It was shown 
that K3 reorganizes the membrane composition in its vicinity, induces positive membrane curvature, and 
enhances the probability of lipid tail protrusions.17 All of these effects are fusion relevant.27 Here we show 
by diffusion and Time-Dependent Fluorescence Shift (TDFS) measurements that CP4K4 and CP12K4 in contrast 
to CP4E4 and CP12E4 influence the bilayer at least to the level of carbonyls. TDFS provides information about 
hydration and mobility of the molecules that are found in the immediate vicinity of an excited probe. Both 
the hydration and mobility can be quantified by the total spectral shift (Δν) and the mean solvent relaxation 
time (τr), respectively. It has been shown that, for Laurdan located at the fully hydrated carbonyl level of a 
phospholipid bilayer, Δν is directly proportional to the hydration and τr to the rigidity of the lipid bilayer at 
the level of the carbonyls.28,29 As follows from Figure 7, 2 mol% of CP4E4 and CP12E4 were not able to induce 
any significant changes in hydration or mobility; and as follows from the lower panel of Figure 5, the 
diffusion of a fluorescent lipid analog DiD remained unaffected by addition of 1 mol % of CP4E4 or CP12E4. 
On the other hand, addition of 2 mol% of both CP4K4 and CP12K4 resulted in the prolongation of τr between 
11 and 15 %, a decrease in ∆ν from 4350 to 4250 cm-1 and an impeded diffusion of DiD (Figure 5 and 6). 
Prolongation of τr is usually accompanied in TDFS experiments by the decrease in ∆ν because of the increase 
in bilayer rigidity, mostly caused by denser lipid packing, and this often leads to dehydration as water 
molecules are expelled to the bulk.30–32 In summary, CP4K4 and CP12K4 do affect the bilayer by increasing 




Figure 7.  The solvent relaxation time τr and the spectral shift ∆ν of Laurdan in DOPC/DOPE/Chol (50/25/25 
mol%) LUVs containing 2 mol% of lipopeptides (LPs).  
 
Molecular view of the initial steps of membrane fusion 
It is generaly accepted nowadays that membrane fusion requires such molecules that bring the opposing 
membranes into close proximity and locally disturb the lipid bilayers in order to reduce the energetic costs 
of membrane fusion. This work should prove that fusion caused by lipopeptides CPnE4 and CPnK4 also 
proceeds according to this general scheme.  
The fusion driven by CPnE4 and CPnK4 is based on coiled-coil formation between peptides E4 and K4. The 
formation of this coiled-coil is intended to mediate close contact of opposing membranes that the peptides 
are anchored in. We have already shown that K4, in contrast to E4, interacts strongly with DOPC/DOPE/Chol 
(50/25/25 mol%) bilayers. Such strong binding is probably facilitated by the specific positioning of lysine 
residues and respective charge distribution within the primary sequence of peptide K4.19 Amphipathic 
helices with this charge distribution pattern are classified as class A1 amphipathic helices and are known to 
interact with zwitterionic lipids.33,34 Both CPnE4 and CPnK4 have been found in DOPC/DOPE/Chol (50/25/25 
mol%) bilayers as monomers. Neither FCCS nor FRET experiments revealed any detectable amount of stable 
homo-oligomers in DOPC/DOPE/Chol (50/25/25 mol%) bilayers at a broad range of lipopeptide 
concentrations 0.05 -1.2 mol%. Such oligomers might potentially reduce the number of monomeric peptides 
which are available for binding to a complementary lipopeptide. Formation of homo-oligomers was 
suggested by previous studies employing circular dichroism spectroscopy. Increased  α-helicity, commonly 
attributed to the homo-coil formation,  was shown for peptides in solution and for lipopeptides 
incorporated in model lipid bilayers at concentration spanning the range at which the fusion normally occurs 
(1-3 mol%).12,13,18,35–37 According to a recent study, elevated α-helicity of CP12K3 does not reflect the peptide 
homo-coiling, but rather membrane snorkelling of K3 moiety into the lipid bilayer. 16 In contrast to CP12K3, 
no such interaction was shown for CP12E3, which was reported to exist in equilibrium between unfolded 
monomers and folded homo-coils at 2 mol%. Although we could not reveal any stable homo-clusters below 
1.2 mol% by our methods, it follows from FCS diffusion measurements that the lipopeptides interfere with 
each other because the diffusion of all lipopeptides is slowed down just because of the presence of the 
lipopeptides more than the diffusion of DiD. Interactions of CPnE4 with CPnK4 are happening in a dense matrix 
of neighbouring lipopeptides. Such a dense environment of surrounding lipopeptides might modulate 
homo- and hetero-coiling of CPnE4 and CPnK4.  
Importantly, binding of K4 to E4 is not efficient. According to single molecule FCCS experiments, the majority 
of CP4E4 and K4 remain unbound to each other when up to a 10-fold excess of K4 is added to CP4E4 containing 
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GUVs. Of note, the cross-correlation amplitude reaches about 30 % of the maximum value that could be 
reached. Furthermore, binding of K4 to CPnE4 rich GUVs is 6 times stronger than to CPnE4 deficient GUVs, 
and as indicated by diffusion measurements, K4 sticks to the bilayer, where it diffuses with almost the same 
speed as the surrounding lipids. Therefore, our FCCS experiments directly prove the exclusive function of 
CPnE4, which is to recruit peptide K4 to the bilayer. Similarly, it appears from FCCS experiments that 
significant amounts of CP4K4 and E4 stay unbound to each other when up to a 10-fold excess of E4 is 
incubated with CP4K4 containing GUVs. The cross-correlation amplitude is even lower in this case as 
compared to the previous one. This occurs because the equilibrium between free CP4K4 and E4 and the 
resulting hetero-coil is shifted in favour of the free components and is overwhelmed by interactions 
between CP4K4 and the lipid bilayer. E4 behaves differently in comparison to K4 in that it interacts with the 
bilayer exclusively by means of the complementary lipopeptide CPnK4. Therefore, the function of CPnK4 is 
actually two-fold: firstly it brings the fusing bilayers into close contact; and secondly it strongly interacts 
with the lipid bilayer.   
Surprisingly, CPnE4 and CPnK4 do not form hetero-coils so efficiently with each other when reconstituted in 
the same bilayer. The efficiency of hetero-coiling is in fact so low that FCCS was not able to reveal any 
detectable amount of CP4E4-Atto-488/CP4K4-Atto-655 pairs (see above). This can be rationalized by the fact 
that CPnK4 and CPnE4 are localized at different distances from the lipid-water interface with a low chance of 
meeting/interacting with each other. The different localization of the peptides along the bilayer normal may 
represent an important mechanism by which the number of free CPnE4 and CPnK4 molecules potentially 
available for binding to an opposing membrane is kept on a high level, enabling efficient fusion. 
Furthermore, it follows from the FRET experiments we performed that the transverse distribution of K4 and 
E4 peptide moiety of CPnK4/CPnE4 molecules is rather broad. Whereas the peptide segment of CPnE4 is 
exposed to the bulk, a considerable fraction of CPnK4 is because of the broad transverse distribution 
imbedded in the bilayer. Previous experiments showed that fusion of CPnE3 or CPnK3 containing LUVs occurs 
only if the length of the poly(ethylene glycol) linker of CPnE3 is so long that it can reach the lipid-water 
interface of the opposing bilayer where majority of CPnK4 is imbedded.38 Therefore, it appears crucial for 
the fusion that the peptide segment of CPnE4 is sufficiently long and exposed to the bulk. The bilayers, which 
do not carry any electric charge, can approach each other up to the equilibrium distance of 2–3 nm. In this 
respect, the distance equal to about 6 nm of Atto-488 attached to CPnE4 from the bilayer surface seems 
optimal for the fusion to occur.  
Lipopeptides CPnE4 in contrast to CPnK4 do not have any observable impact on DOPC/DOPE/Chol (50/25/25 
mol%) bilayers. The peptide segments K4 of CPnK4 molecules densely cover the surface of the bilayer at 2 
mol% of CPnK4, which leads to increased microviscosity and decreased polarity of the carbonyl region of the 
lipid bilayer. Importantly, dehydration of the lipid bilayer was shown to play an important role during 
membrane fusion.39,40 Moreover, the diffusion of the lipid analogue DiD becomes impeded by 1 mol% of 
CPnK4. These findings are in line with a peptide insertion model with the helical peptide inserted in parallel 
to the membrane surface and with the hydrophobic face penetrating into the hydrophobic core of the 
bilayer.17 From the macroscopic point of view, the insertion of K4 was reported to be accompanied by local 
membrane deformations, which are manifested by an altered bilayer curvature and lipid tail protrusions. 
These initial steps of membrane fusion are followed by fusion of the proximal leaflets and lipid mixing 
culminated by opening of a fusion pore and content mixing. However, how these later stages of membrane 
fusion occur still remains a question. 
 
Lipopeptide versus SNARE mediated membrane fusion 
The fusion system based on CPnE4 and CPnK4 is a reduced system derived from SNARE proteins which 
constitute central molecules in the fusion machinery of eukaryotic cells.12 This implies that the fusion 
mechanisms for both the reduced and original systems do not need to be fully identical. Both mechanisms 
are driven by self-association of alpha-helixes containing several heptad repeat sequences with high 
propensity to form coiled coils.41,12 Nevertheless, whereas the lipopeptide mediated fusion requires only 
two complementary molecules CPnE4 and CPnK4, the SNARE mediated fusion is based on self-association of 
at least one v-SNARE (synaptobrevin) and two t-SNARE (syntaxin and SNAP-25) proteins.41 In both cases, the 
complex formation is accompanied by energy release which is used to bring the opposing membranes into 
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close proximity.42 Critical steps in membrane fusion represent dehydration of the lipid bilayer and formation 
of hydrophobic contacts between the approaching bilayers.6 These contacts are formed by hydrophobic acyl 
chains protruding to the lipid-water interface.39  There is a good agreement that both the lipopeptides as 
well as the SNAREs are able to increase the hydrophobicity of the lipid-water interface.17,41 However, 
whereas in case of the lipopeptides it is only CPnK4 that is able to dehydrate the lipid bilayer, in case of 
SNAREs dehydration has so far been experimentally demonstrated only for synaptobrevin or for the whole 
SNARE complex.43,44  
A fundamental difference between both mechanisms might lie in the fact that other parts of a SNARE 
molecule may as well contribute to the fusion. These regions include the transmembrane domain, which 
anchors the protein in the membrane, and the linker region, which connects the transmembrane domain 
with the bulk alpha helical repeats. Reports have appeared that the linker region is able to transmit the 
stress induced by self-assembly of SNAREs into the membrane and to push the transition from hemi to full 
fusion by its positively charged residues.45,46,42 The transmembrane domain, on the other hand, should be 
critical for accomplishing the fusion by opening a fusion pore.47 It could also be responsible for homo- and 
hetero-oligomerization of SNAREs, which would explain why homo-oligomers of SNAREs are formed more 
efficiently than those formed by the lipopeptides.48 The system based on the lipopeptides represents the 
most simplified system where fusion still occurs. From this perspective it seems that the transmembrane 
domain and the linker region of SNAREs have rather a regulatory than an indispensable function. This view 
has recently been supported by fusion experiments performed on lipid anchored SNAREs during 
neurotransmitter release, but it will require further supportive experiments on other systems, too.49 
Conclusions 
Fusion of intracellular membranes in nature is mediated by so-called SNARE proteins. A minimal model 
system for membrane fusion inspired by these proteins consists of cholesterol serving as a lipid membrane 
anchor, a poly(ethylene glycol) linker and either a cationic peptide K4 or its counterpart an anionic peptide 
E4. The behaviour of the complementary lipopeptides CPnE4 and CPnK4 is in many ways different, which fits 
with their previously uncovered distinct roles during fusion. The lipopeptide molecules CPnK4 exist in lipid 
bilayers predominantly as monomers where they strongly interact with the lipid bilayer. During the initial 
steps of membrane fusion, the main role of CPnK4 is to disrupt the bilayer and poise it for undergoing fusion. 
On the other hand, CPnE4 molecules work as lipid anchors. The peptide moieties are exposed to the bulk, 
where they search for the complementary CPnK4 molecules, recruiting them to their own bilayer. The 
efficiency of hetero-coil formation is very low and possible only when the lipopeptides approach each other 
as constituents of different bilayers. When the complementary lipopeptides are incorporated in the same 
bilayer the formation of hetero-coils is disabled by different localization of the peptides along the normal of 
the lipid bilayer. This mechanism keeps the number of monomeric lipopeptides that can hetero-coil with a 
complementary lipopeptide on the neighbouring bilayer at a high level, enabling efficient fusion. All these 
facts represent important findings that need to be taken into account when a model for later stages of 
fusion is developed. 
Methods 
General. Details of all chemicals, synthesis of the (lipo)peptides and formation of GUVs can be found in the 
supporting information. 
Sample preparation for FCS (fluorescence correlation spectroscopy) and FCCS (fluorescence cross-correlation 
spectroscopy). The lipopeptides dissolved in methanol were added to the GUVs by keeping the volume of 
added solvent below 1% of the total volume. Prior to a measurement, the GUVs were incubated with the 
lipopeptides for at least 30 minutes. Finally, 40 μl of GUVs were added to a microscope chamber (Nunc® 
Lab-Tek® Chamber) filled with 360 μl of phosphate buffer (25mM PBS, 100mM KCl, 1mM EDTA, pH 7.4, 255 
mOsm) and precoated with BSA-biotin/streptavidin for immobilization of the GUVs at the bottom of the 
microscope chamber.  The probe to lipid ratio was between 0.1% and 0.005 %. The bilayer of GUVs 
contained in addition a lipophilic marker DiD at 0.001 mol%.  
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Sample preparation for FLIM-FRET (fluorescence lifetime imaging of Förster resonance energy transfer). The 
preparation procedure was similar to that one described in the previous section except that the lipopeptides 
were mixed with the lipids already before the formation of GUVs. 40 μl of GUVs were added to a microscope 
chamber (Nunc® Lab-Tek® Chamber), filled with 360 μl of phosphate buffer (25mM PBS, 100mM KCl, 1mM 
EDTA, pH 7.4, 255 mOsm) and precoated with BSA-biotin/streptavidin. Prior to a measurement, the GUVs 
were left for about 15 min to settle down at the bottom of a chamber.  
Sample preparation for Time-Dependent Fluorescence Shifts (TDFS) of Laurdan. Appropriate volumes of 
lipids dissolved in CHCl3 and Laurdan dissolved in MetOH were mixed in glass tubes and dried under nitrogen 
stream. To get rid of the remaining organic solvents the lipid films were left in vacuum for at least two hours. 
The resulting lipid films were resuspended in phosphate buffer (25mM PBS, 100mM KCl, 1mM EDTA, pH 
7.4). Large unilamellar vesicles (LUVs) were formed by extrusion through filters with a defined pore size of 
100 nm (Avestin, Ottawa, Canada). Final concentrations of lipids and Laurdan were 1mM and 0.01mM, 
respectively. The samples were equilibrated for at least 15 minutes prior to a measurement. 
FLIM-FRET, FCS and FCCS measurements were performed on a home build confocal microscope consisting 
of an inverted confocal microscope body IX71 (Olympus, Hamburg, Germany). The samples were excited by 
pulsed diode lasers (LDH-P-C-470, λ = 470 nm and LDH-D-C-635, λ = 635 nm, both produced by Picoquant, 
Germany) with the repetition rate of 12.5 MHz for each of the laser lines.  The laser light was pulsed 
alternatively to avoid artefacts caused by signal bleed-through. The light was up-reflected to a water 
immersion objective (UPLSAPO 60x, Olympus) with a 470/635 nm dichroic mirror. The signal was detected 
by two single photon avalanche diode detectors equipped with 515/50 and 685/50 nm band pass filters 
(Chroma Rockingham, VT).  
Z-scans were conducted at the top of a single GUV. The membrane was scanned vertically in 15 steps 
separated 150 nm apart from each other. 60-seconds-long intensity trace was recorded at each position. To 
obtain the average diffusion coefficients measurements on at least five different GUVs were done. Further 
details on the analysis of data can be found for instance in 50. During acquisition of FLIM-FRET data, GUVs 
were scanned at the cross-section with the resolution of 512 x 512 pixels (0.6 ms/pixel). Decays from at 
least five different GUVs were summed up and used for further analysis. The temperature was kept at 25°C. 
The analysis of FLIM-FRET, FCS and FCCS is described in more detail in supporting information (SI) of this 
paper.  
 TDFS measurements. Steady-state emission spectra were measured on Fluorolog-3 spectrofluorometer 
(model FL3–11; Jobin Yvon Inc., Edison, NJ, USA) equipped with a xenon-arc lamp whereas time-resolved 
fluorescent decays were recorded using a 5000U Single Photon Counting setup equipped with a cooled 
Hamamatsu R3809U-50 microchannel plate photomultiplier (IBH, UK). Laurdan was excited at 373 nm with 
an IBH NanoLed 11 laser diode. The data were collected for a series of wavelengths ranging from 400 nm to 
540 nm with a 10 nm step. Potentially present scattered light was eliminated by a cut-off emission filter > 
399 nm. Each decay was fitted with a multi-exponential function using the iterative reconvolution procedure 
(IBH DAS6 software). Time-resolved emission spectra (TRES) were reconstructed from the recorded series 
of fluorescent decays and the corresponding steady-state emission spectrum.51 To determine positions of 
maxima in TRES, ν(t), the TRES spectra were fitted by a log-normal function. The total spectral shift ∆ν was 
calculated as Δ𝜈𝜈 =  [𝜈𝜈(0) − 𝜈𝜈(∞)]. The so-called correlation function of solvent relaxation is expressed as 
𝐶𝐶(𝑡𝑡) = [𝜈𝜈(𝑡𝑡) − 𝜈𝜈(∞)]/[Δ𝜈𝜈] and allows for quantitative description of solvation dynamics occurring in the 
system. Finally, the mean solvent relaxation time equals 𝜏𝜏𝑟𝑟 = ∫ 𝐶𝐶(𝑡𝑡)d𝑡𝑡
∞
0  per definition. TDFS experiments 
were performed at 283 K. 
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